Fidelity Investments’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25
Closed -$41 5630
2023
Q2
$41 Buy
25
+19
+317% +$35 ﹤0.01% 5053
2023
Q1
$14 Sell
6
-1
-14% -$5 ﹤0.01% 5148
2022
Q4
$39 Buy
+7
New +$42 ﹤0.01% 4993
2021
Q4
Sell
-28
Closed 5117
2021
Q3
$0 Buy
+28
New +$505 ﹤0.01% 5239
2019
Q1
Sell
-18
Closed -$1K 4341
2018
Q4
$1K Sell
18
-19,847
-100% -$2.28M ﹤0.01% 3449
2018
Q3
$3.01M Sell
19,865
-8,998
-31% -$1.29M ﹤0.01% 2284
2018
Q2
$5.18M Sell
28,863
-4,414
-13% -$1.03M ﹤0.01% 2142
2018
Q1
$8.32M Buy
33,277
+9,176
+38% +$2.52M ﹤0.01% 2009
2017
Q4
$6.91M Hold
24,101
﹤0.01% 2067
2017
Q3
$7.3M Hold
24,101
﹤0.01% 2048
2017
Q2
$5.63M Buy
24,101
+883
+4% +$231K ﹤0.01% 2136
2017
Q1
$7.79M Buy
23,218
+4,731
+26% +$1.14M ﹤0.01% 2049
2016
Q4
$3.77M Buy
18,487
+18,312
+10,464% +$4.37M ﹤0.01% 2246
2016
Q3
$61K Buy
+175
New +$46.3K ﹤0.01% 2641
2016
Q2
Sell
-13,977
Closed -$3.76M 2714
2016
Q1
$3.76M Buy
13,977
+1,475
+12% +$394K ﹤0.01% 2240
2015
Q4
$5.25M Buy
12,502
+103
+0.8% +$46.1K ﹤0.01% 2180
2015
Q3
$5.64M Sell
12,399
-21,296
-63% -$9.42M ﹤0.01% 2140
2015
Q2
$17M Buy
33,695
+16
+0% +$7.34K ﹤0.01% 1800
2015
Q1
$17M Buy
33,679
+5,009
+17% +$3.05M ﹤0.01% 1790
2014
Q4
$17.2M Sell
28,670
-3,138
-10% -$1.26M ﹤0.01% 1802
2014
Q3
$9.9M Buy
31,808
+4,580
+17% +$1.65M ﹤0.01% 2020
2014
Q2
$10.7M Buy
27,228
+5,537
+26% +$2.28M ﹤0.01% 2043
2014
Q1
$12M Buy
+21,691
New +$14.8M ﹤0.01% 1958

Other funds holding ACGN

Fidelity Investments's ACGN Position: Q3 2023 in Review

Fidelity Investments sold out of Aceragen Inc (ACGN) in Q3 2023, closing a stake of 25 shares — an estimated $41 sold.

Fidelity Investments first reported a position in ACGN in Q1 2014 and held it in 23 quarters. The position peaked at $17.2M in Q4 2014. 3 funds tracked by Wall St. Rank hold ACGN as of Q3 2023.

  • Fidelity Investments reported no remaining Aceragen Inc position as of Q3 2023 after selling out during the quarter.
  • Fidelity Investments sold 25 Aceragen Inc shares in Q3 2023, an estimated $41.
  • Fidelity Investments first reported a position in Aceragen Inc in Q1 2014 and held it in 23 quarters.
  • Fidelity Investments's Aceragen Inc position peaked at $17.2M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.